Softwr

Healthcare · head to head

Sysmex vs Woebot Health

Sysmex logo

Sysmex

Healthcare

Haematology and urinalysis analysers sold with the middleware that decides which results a scientist ever sees

From
On request
Rated
-
Full reviewWebsite
Woebot Health logo

Woebot Health

Healthcare

Conversational CBT chatbot that withdrew from consumer distribution and now sells only to payers and providers

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Sysmex the middleware is not realistically separable from the instrument contract, so a laboratory that likes Caresphere but wants another vendor analyser has no clean path to buying just the software.; Woebot Health the company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • They diverge on capability: Sysmex covers Caresphere autovalidation, Woebot Health covers Scripted CBT dialogue.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Sysmex and Woebot Health actually diverge.

Attributes where Sysmex and Woebot Health differ
AttributeSysmexWoebot Health
PlatformsWeb, Windows, On-premiseiOS, Android, Web

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Sysmex

  • Caresphere autovalidation
  • Delta and moving average QC
  • WAM rule sets
  • Fleet telemetry
  • Reagent inventory tracking
  • Extended white cell parameters
  • LIS interfacing
  • Multi-site harmonisation

Only in Woebot Health

  • Scripted CBT dialogue
  • Mood tracking
  • Crisis routing
  • Between-session support
  • Payer deployment
  • Provider copilot positioning
  • Research licensing
  • Population reporting

What people use each for

The jobs each tool is most often brought in to do.

Sysmex

  • A hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centrenot Woebot Health
  • A pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientistsnot Woebot Health
  • A blood sciences service consolidating haematology, coagulation and urinalysis onto one middleware layer to remove three separate QC workflowsnot Woebot Health
  • A laboratory running 24 hour service that needs remote analyser telemetry so an overnight fault is triaged before the morning shift arrivesnot Woebot Health

Woebot Health

  • A health plan wanting a low intensity behavioural health option for members on a waiting list for therapynot Sysmex
  • A provider organisation offering structured between-session CBT practice to patients already in treatmentnot Sysmex
  • A research group running a trial that needs a clinically scripted rather than generative conversational agent for safety reasonsnot Sysmex
  • A payer targeting a specific population such as postpartum members where scripted CBT content already existsnot Sysmex

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Sysmex

  • The middleware is not realistically separable from the instrument contract, so a laboratory that likes Caresphere but wants another vendor analyser has no clean path to buying just the software.
  • Reagent rental agreements set a minimum annual test volume, and a laboratory whose activity falls after a service reconfiguration keeps paying against a floor it no longer reaches.
  • Regulatory clearance is granted per parameter and per region, so a flag or extended parameter that a European laboratory relies on may not be released for clinical use on the same analyser in the United States.
  • Interfacing to a non-Sysmex laboratory information system is a project, not a configuration step, and integration effort is often quoted separately from the instrument contract.
  • Autovalidation rule sets are configured locally, so the gains depend entirely on whether the laboratory has the clinical governance capacity to write, validate and audit those rules; buying the software does not deliver the saving on its own.

Woebot Health

  • The company withdrew its consumer app in June 2025 after concluding FDA marketing authorisation was not achievable at acceptable cost, which is a plain signal about both regulatory position and commercial durability.
  • It is not an FDA cleared treatment for any indication, so it cannot be positioned to members as therapy and cannot substitute for a covered behavioural health benefit.
  • The scripted, non-generative design that makes it safe also makes it feel rigid next to current conversational AI, and engagement drops off quickly once users hit the edges of the script.
  • Published evidence is short-horizon symptom change in selected populations, mostly young adults, with little evidence of durable benefit or effect at whole-population scale.
  • With consumer distribution gone, the remaining business depends on a small number of payer and provider contracts, so a buyer should assume real vendor continuity risk over a multi-year term.

Pricing, plan by plan

Sysmex

On request
  • Reagent rental or cost per reportable result contract$undefined/year
    • Analyser hardware, reagents, service and Caresphere middleware bundled into a price per test
    • Five to seven year term typical
    • Minimum annual test volume commitment

Woebot Health

On request
  • Woebot for payers and providers$undefined/year
    • Contracted per member per month or as a population licence
    • Sold to health plans and provider organisations, not to employers or individuals
    • No consumer purchase route since the app closed in June 2025

Which should you pick?

Choose Sysmex if

  • You need caresphere autovalidation.
  • You work on Web, Windows, On-premise.
  • You also want delta and moving average qc.
Sysmex review

Choose Woebot Health if

  • You need scripted cbt dialogue.
  • You work on iOS, Android, Web.
  • You also want mood tracking.
Woebot Health review

Questions people ask

Is Sysmex or Woebot Health better?
Neither clearly leads. Sysmex starts at On request and Woebot Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Sysmex or Woebot Health?
Sysmex starts at On request and Woebot Health at On request.
Does Sysmex or Woebot Health run on more platforms?
Sysmex runs on Web, Windows, On-premise. Woebot Health runs on iOS, Android, Web.
What is Sysmex best used for?
Sysmex is most often used for a hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centre, a pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientists, a blood sciences service consolidating haematology, coagulation and urinalysis onto one middleware layer to remove three separate qc workflows, a laboratory running 24 hour service that needs remote analyser telemetry so an overnight fault is triaged before the morning shift arrives. Of those, a hospital network standardising full blood count reporting across six laboratories so a result released at a district hospital carries the same rules as the tertiary centre and a pathology group trying to raise autovalidation rates to absorb rising demand without recruiting more biomedical scientists are not what Woebot Health is typically brought in for.
What can Sysmex do that Woebot Health cannot?
Sysmex covers Caresphere autovalidation, Delta and moving average QC, WAM rule sets, Fleet telemetry. Woebot Health covers Scripted CBT dialogue, Mood tracking, Crisis routing, Between-session support.

Answered from the vendors’ own pages

Sysmex: Can I buy Caresphere without Sysmex analysers?

Not in practice. It is licensed as part of the instrument and reagent agreement, and its value depends on Sysmex-specific parameters and flags.

Woebot Health: Is Woebot still available?

Not to consumers. The consumer app closed in June 2025. The company continues to offer the product to payers, providers and researchers.

Sysmex: Is Sysmex software FDA cleared?

Clearance attaches to the analysers and to individual reported parameters, not to the middleware as a whole. Check the specific parameter and the specific market, because clearances differ between the United States, Europe and Japan.

Woebot Health: Is it FDA cleared?

No. It held Breakthrough Device designation but never obtained marketing authorisation, and the founder cited the cost of that pathway as the reason for closing the consumer app.

Sysmex: How is it priced?

Per reportable result, or as a reagent rental with a minimum annual volume. There is no per user or per seat price.

Woebot Health: Is it generative AI?

Historically no. The dialogue is clinician-written and rule-based, a deliberate safety choice that limits how naturally it converses.

Sysmex: What is the contract length?

Typically five to seven years, aligned to instrument depreciation, with reagent pricing fixed or indexed over the term.

Woebot Health: What does the evidence show?

Randomised studies reported reduced depressive symptoms over short periods in selected populations, notably young adults. That is symptom change in a trial, not demonstrated population outcomes.

Share

Related pages

More on Sysmex

More on Woebot Health

Keep looking

Other head to heads